Outcomes4Me, founded in 2017 and headquartered in the United States, is at the forefront of democratizing cancer care through its innovative use of AI and machine learning technology. Their free platform empowers patients by offering personalized, FDA- and doctor-approved treatment insights tailored to individual diagnoses. Additionally, the platform provides access to relevant clinical trials and genetic testing options, making it a comprehensive resource for cancer patients.
Outcomes4Me is notably the first digital platform to integrate with the prestigious NCCN Clinical Practice Guidelines in Oncology, reinforcing its credibility and utility in the field. The company has earned several accolades in 2024, including the Fast Company World Changing Idea and the MassTLC Tech Top 50: CEO of the Year Award.
The company closed a $12.00M Series A investment on 28 April 2021, backed by prominent investors such as Asset Management Ventures, Sierra Ventures, Northpond Ventures, IRA Capital, and Merstal Ltd.